TechCare Unveils New Novokid + Lice Treatment Product for Use in Schools, Camps and Clinics

Wednesday, May 3, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

Breakthrough product eliminates head lice with all-natural, pesticide-free 10 minute vapor treatment

ROSH HA'AIN, Israel, May 3, 2017 /PRNewswire/ --

TechCare Corp. (OTCQB: TECR),

a technology company with a revolutionary platform that uses cold vapor technology for natural health and beauty treatments, today announced it has designed and developed Novokid +, an institutional grade head lice treatment product based on its original Novokid for home use. TechCare expects to commercially launch Novokid + in the first quarter of 2018.

Novokid is a new paradigm in the treatment of head lice, a $1.8 billion global market.  Current over-the-counter treatments are toxic, often ineffective and expensive. According to the Journal of Medical Entomology, 98% of lice have developed resistance to existing treatments in the U.S. and they are now referred to as "super-lice". Most current treatments contain pesticides, alcohol or silicone, which are all associated with a wide variety of hazardous side effects. Novokid is a non-pesticide, natural, plant-based and eco-friendly solution that eliminates lice and super lice with a 10 minute dry treatment. This compares with current treatments that required 20-40 minutes of shampooing and daily combing.

While the Novokid vaporizer for home use is battery operated, the Novokid + vaporizer, designed for higher volume daily use, plugs into an electrical outlet. Both Novokid products combine disposable single use capsules containing the all-natural active ingredient, a vaporizer which enables release of the vaporized compound from the capsule into the cap, and a proprietary head cap that fits snugly around the hairline and encloses the vaporized active ingredient.  Novokid and Novokid + are invented by TechCare scientists. Patents are issued and pending in the U.S., Europe, Israel, and many other major markets.

"We developed Novokid + in response to numerous requests from the marketplace for a product designed to serve a higher volume of daily use in an institutional setting. Our market research indicates schools, children's camps, medical clinics and HMOs would benefit from, and are interested in, having Novokid + in their facilities," stated TechCare Chairman and CEO, Zvi Yemini. "The very easy to use, all natural, dry vapor technology requires no shampooing, and therefore perfectly lends itself to use in institutional settings."

About TechCare Corp. 

TechCare is a technology company engaged in the design, development and commercialization of an innovative platform utilizing cold vaporization of various natural, plant-based compounds, to enable a wide variety of treatment solutions. Inspired by simple, natural treatments that have been used for generations, TechCare's renowned scientists combine traditional wisdom with innovative, proprietary technology and years of research to create solutions that answer the needs of today's consumers. Products scheduled for commercial launch in 2017 include Novokid and Shine. Novokid is a revolutionary anti-lice technology that eliminates lice with one simple 10 minute treatment with no coming or washing. Novokid is 100% natural and pesticide free. Shine, a haircare product, rejuvenates hair by returning its natural health, shine, body and luster by removing residues left over from other haircare products. Additional products are in development and slated for launch in 2018.

Notice Regarding Forward-Looking Statements  

This communication does not constitute an offer to purchase or exchange or the solicitation of an offer to sell or exchange any securities of the Company. This communication contains certain statements that are neither reported financial results nor other historical information and other statements concerning the Company.

These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives and expectations with respect to future operations, events, products and services and future performance. Forward-looking statements are generally identified by the words "will", "expects", "anticipates", "believes", "intends", "estimates", "target", and similar expressions. These and other information and statements contained in this communication constitute forward-looking statements for purposes of applicable securities laws.

Although management of the Company believes that the expectations reflected in the forward looking statements are reasonable, investors and security holders are cautioned that forward looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of the Company, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by the forward-looking information and statements, and the Company cannot guarantee future results, levels of activity, performance or achievements. Factors that could cause actual results to differ materially from those estimated by the forward-looking statements contained in this communication include, but are not limited to: trends in target markets; the Company's ability to develop new technology and products; effects of competition in the Company's main markets; challenges to or loss of intellectual property rights; ability to establish and maintain strategic relationships in its major businesses; profitability of the growth strategy; and changes in global, political, economic, business, competitive, market and regulatory forces. Moreover, neither the Company nor any other person assumes responsibility for the accuracy and completeness of such forward-looking statements. The forward-looking statements contained in this communication speak only as of the date of this communication and the Company or its representatives are under no duty, and do not undertake, to update any of the forward-looking statements after this date to conform such statements to actual results, to reflect the occurrence of anticipated results or otherwise except as otherwise required by applicable law or regulations.

SOURCE TechCare Corp


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store